LogicBio Therapeutics
Foster City
About LogicBio Therapeutics
LogicBio develops gene therapy vectors for previously incurable genetic and infectious diseases. It is committed to delivering genetic medicine to pediatric patients with rare diseases. Their proprietary technology based on the non-pathogenic adeno-associated viral vector offers superior efficiency and safety compared to all competitors on the market and is uniquely suited for the treatment of children as well as adults.
Company Facts
- Operating status: Closed
- Company type: For Profit
- IPO status: Delisted
- Employees: 51 – 100
- Estimated revenue: $1K – $10K
- Total funding: $69.0M
- Funding stage: M&A
- Last round: Post-IPO Equity (Jan 2021)
- Ticker: nasdaq:LOGC
- Website: logicbio.com
- Phone: +1 1042 833 8594
Industries & Categories
Biotechnology, Genetics
Social Profiles
Canonical: https://fsome.com/organization/logicbio-therapeutics-206623 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.